Insulet (PODD) Accumulated Expenses (2010 - 2026)

Insulet has reported Accumulated Expenses for 17 years, with the latest figure at $519.0 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses rose 37.08% year-over-year to $519.0 million; the trailing twelve-month figure through Mar 2026 stood at $519.0 million (up 37.08% YoY), and the FY2025 full-year result was $586.7 million, up 58570.0% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $519.0 million, down from $586.7 million in the prior quarter.
• The five-year high for Accumulated Expenses was $586.7 million in Q4 2025, with the low at $900000.0 in Q3 2025.
• Historically, Accumulated Expenses has averaged $257.0 million across 5 years, with a median of $282.8 million in 2023.
• Annual changes were most pronounced in 2023 — Accumulated Expenses tumbled 97.04% — and 2025, when it surged 58570.0%.
• Insulet's Accumulated Expenses stood at $301.0 million in 2022, then plunged by 97.04% to $8.9 million in 2023, then sank by 88.76% to $1.0 million in 2024, then surged by 58570.0% to $586.7 million in 2025, then fell by 11.54% to $519.0 million in 2026.
• The last three Accumulated Expenses figures came in at $519.0 million (Q1 2026), $586.7 million (Q4 2025), and $900000.0 (Q3 2025), per Business Quant data.